Group III MGlu Receptor Tocriset | Ligand Sets | Selection Of 5 Group III MGlu Receptor Ligands (Cat. Nos. 0103, 1220, 0972, 0803 & 1209)

Category:

Cat.No.	Product Name
1828	Group III mGlu Receptor Tocriset^TM
Contents: L-AP4 (Cat. No. 0103) selective group III mGlu agonist (RS)-PPG (Cat. No. 1220) potent, selective group III agonist CPPG (Cat. No. 0972) potent group III antagonist MSOP (Cat. No. 0803) specific group III antagonist LY 341495 (Cat. No. 1209) potent group II/group III antagonist

Price and Availability

Click here for full price details of
Group III mGlu Receptor Tocriset

Biological Activity:

Contains the above products as lyophilised solids or pre-dissolved in DMSO to a stock concentration of 10 mM in 0.5ml. The products can be used to investigate the pharmacology of Group III mGlu receptors.

Technical Data:

Please see individual product listings for specific technical data.

Click here for further information about Tocriset purity and uses.

Tocriset booklet:

View current batch
For specific/earlier batch please select:

References:

Please see individual product listings for specific references.

View related products by Pharmacological Action or by Research Area

Keywords: Group III MGlu Receptor Tocriset, Ligand Sets, Selection Of 5 Group III MGlu Receptor Ligands (Cat. Nos. 0103, 1220, 0972, 0803 & 1209), Tocris Bioscience

New Product Guide

	Our latest New Product Guide highlights over 140 new products.
Request Copy / View PDF

Purity To Rely On

When choosing reagents for an experiment, the prime consideration is often to obtain the highest quality products available.

Unlike other suppliers, our in-house QC team carry out multiple analytical tests to thoroughly assess the purity of our reagents before they are offered for sale.

This accurate purity data is available on a batch-specific basis for every product via our website. At Tocris we work hard to ensure that we always supply to the highest possible standards of purity.

New Products in this Area

	2180	Endocannabinoid Tocriset^TM
	Selection of 5 endogenous cannabinoids (Cat. Nos. 1339, 1298, 1568, 1411 and 1569)
	2179	Cannabinoid Receptor Agonist Tocriset^TM
	Selection of 5 cannabinoid receptor agonists (Cat. Nos. 1339, 1298, 0949, 0966 and 1038)
	2178	Cannabinoid CB₁Receptor Tocriset^TM
	Selection of 3 CB₁ receptor ligands (Cat. Nos. 1319, 1121 and 1117)
	1873	β-Adrenoceptor Agonist Tocriset^TM
	Selection of 3 β-adrenoceptor agonists (Cat. Nos. 0948, 1747 and 1660)
	1871	α₁-Adrenoceptor Tocriset^TM
	Selection of 5 α₁-adrenoceptor ligands (Cat. Nos. 1052, 0888, 1006, 0946 and 0623)
	1875	Mixed Adrenergic Tocriset^TM
	Selection of 5 mixed adrenoceptor ligands (Cat. Nos. 0888, 0425, 1747, 0623 and 0952)
	1877	Serotonin Uptake Inhibitor Tocriset^TM
	Selection of 5 serotonin uptake inhibitors (Cat. Nos. 0596, 1427, 0457, 0927 and 1033)
	1876	Histamine H₃ Receptor Tocriset^TM
	Selection of 5 histamine H₃ receptor ligands (Cat. Nos. 0729, 0569, 0752, 0779 and 0644)

for new product e-alerts

User ID
Password